✦ LIBER ✦

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation

✍ Scribed by Accurso, Frank J.; Rowe, Steven M.; Clancy, J.P.; Boyle, Michael P.; Dunitz, Jordan M.; Durie, Peter R.; Sagel, Scott D.; Hornick, Douglas B.; Konstan, Michael W.; Donaldson, Scott H.; Moss, Richard B.; Pilewski, Joseph M.; Rubenstein, Ronald C.; Uluer, Ahmet Z.; Aitken, Moira L.; Freedman, Steven D.; Rose, Lynn M.; Mayer-Hamblett, Nicole; Dong, Qunming; Zha, Jiuhong; Stone, Anne J.; Olson, Eric R.; Ordoñez, Claudia L.; Campbell, Preston W.; Ashlock, Melissa A.; Ramsey, Bonnie W.

Book ID: 118175916
Publisher: Massachusetts Medical Society
Year: 2010
Tongue: English
Weight: 760 KB
Volume: 363
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa0909825

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in ion transport biomarkers

Improvement in ion transport biomarkers and spirometry with the investigational CFTR potentiator VX-770 in subjects with cystic fibrosis and the G551D-CFTR mutation

✍ S.M. Rowe; F.J. Accurso; J.P. Clancy; M.P. Boyle; J.M. Dunitz; P.R. Durie; S.D. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

61* VX-770 in subjects with cystic fibro

61* VX-770 in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation

✍ P.A. Flume; D.S. Borowitz; T.G. Liou; H. Li; K. Yen; C.L. Ordonez; D.E. Geller 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Effect of VX-770 (Ivacaftor) and OAG on

Effect of VX-770 (Ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells

✍ Vachel, Laura; Norez, Caroline; Becq, Frédéric; Vandebrouck, Clarisse 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 431 KB

46 Hyperpolarized Gas MRI of ivacaftor t

46 Hyperpolarized Gas MRI of ivacaftor therapy in subjects with cystic fibrosis who have the G551D-CFTR mutation

✍ T. Altes; M.A. Johnson; G.W. Miller; J.P. Mugler; L. Flors; J. Mata; C.L. Salina 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

WS1.1 The effect of ivacaftor, a CFTR po

WS1.1 The effect of ivacaftor, a CFTR potentiator, in patients with cystic fibrosis and a non-G551D-CFTR gating mutation, the KONNECTION study

✍ De Boeck, K.; Munck, A.; Walker, S.; Faro, A.; Hiatt, P.; Chan, J.; Gilmartin, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 70 KB

WS6.5 Ivacaftor in subjects 6 to 11 year

WS6.5 Ivacaftor in subjects 6 to 11 years of age with cystic fibrosis and the G551D-CFTR mutation

✍ J.C. Davies; H. Li; K. Yen; R. Ahrens 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB